Chris Freeman - Jan 1, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Stock symbol
GH
Transactions as of
Jan 1, 2024
Transactions value $
-$17,150
Form type
4
Date filed
1/3/2024, 07:45 PM
Previous filing
Dec 15, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +1.93K +14.52% $0.00 15.2K Jan 1, 2024 Direct
transaction GH COMMON STOCK Tax liability -$17.1K -634 -4.17% $27.05 14.6K Jan 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1.93K -8.33% $0.00 21.2K Jan 1, 2024 COMMON STOCK 1.93K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable for Restricted Stock Units.